Literature DB >> 30184325

A matter of time: The necessity of temporal language in research on health conditions that present with autism spectrum disorder.

Eric Rubenstein1, Lauren Bishop-Fitzpatrick1,2.   

Abstract

Relatively consistent findings from recent studies using population-level data identify heightened physical and psychiatric morbidity in autistic people compared to the general population. Health problems that commonly present with autism spectrum disorder (ASD) are generally discussed in the literature as "co-occurring" or "comorbid" regardless of their known or hypothesized causal mechanisms. In this commentary, we introduce a new temporally focused terminology to describe health conditions that present with ASD. Emphasizing the temporal development of health conditions in research will help the field understand whether conditions are (1) "truly co-occurring" (share an etiologic origin with ASD in utero and are a defining characteristic of a subphenotype), (2) "resulting" (caused by ASD related disparity or the health effect of behaviors developed to cope with ASD symptoms), or (3) "associated" (conditions more common in individuals with ASD with etiology not yet known or hypothesized, or an artifact of diagnostic process or trends). Whether a health condition is "truly co-occurring", "resulting", or "associated" has implications for how we design interventions to prevent and treat health conditions in people on the autism spectrum. Ultimately, we think that using clear and temporally focused language can set us on a path to better deduce etiology and develop effective prevention and intervention efforts for health conditions that impact the lives of autistic individuals. We hope that this approach to temporal language to describe health conditions that present with ASD promotes thought and discussion in research, advocate, and autistic communities. Autism Research 2019, 12: 20-25.
© 2018 International Society for Autism Research, Wiley Periodicals, Inc. LAY SUMMARY: Research finds autistic people have more health problems than the general population but we do not understand why. In this commentary, we argue researchers need to use language describing the timing of health problems in autistic people, specifying whether problems truly co-occur (share a cause), result from autism-related disparities, or are more common in autistic people for an unknown reason. Clarifying language can provide more specificity in research and improve efforts to prevent and treat health problems in autistic people. © 2018 International Society for Autism Research, Wiley Periodicals, Inc.

Entities:  

Keywords:  aging; epidemiology; health; mental health

Mesh:

Year:  2018        PMID: 30184325      PMCID: PMC6325000          DOI: 10.1002/aur.2010

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  5 in total

1.  Is the Autism Boom Headed for Medicaid? Patterns in the Enrollment of Autistic Adults in Wisconsin Medicaid, 2008-2018.

Authors:  Eric Rubenstein; Lauren Bishop
Journal:  Autism Res       Date:  2019-07-17       Impact factor: 5.216

2.  The Physical and Mental Health of Middle Aged and Older Adults on the Autism Spectrum and the Impact of Intellectual Disability.

Authors:  Lauren Bishop-Fitzpatrick; Eric Rubenstein
Journal:  Res Autism Spectr Disord       Date:  2019-01-29

3.  Is Autism Inborn And Lifelong For Everyone?

Authors:  Paul Whiteley; Kevin Carr; Paul Shattock
Journal:  Neuropsychiatr Dis Treat       Date:  2019-10-07       Impact factor: 2.570

Review 4.  A capabilities approach to understanding and supporting autistic adulthood.

Authors:  Elizabeth Pellicano; Unsa Fatima; Gabrielle Hall; Melanie Heyworth; Wenn Lawson; Rozanna Lilley; Joanne Mahony; Marc Stears
Journal:  Nat Rev Psychol       Date:  2022-09-05

5.  Epilepsy in adulthood: Prevalence, incidence, and associated antiepileptic drug use in autistic adults in a state Medicaid system.

Authors:  Lauren Bishop; Kiley J McLean; Eric Rubenstein
Journal:  Autism       Date:  2020-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.